EBRT utilisation rate | Central nervous System | Lower gastrointestinal tract | Female genital organs | Head and neck | Breast | Trachea, bronchus and lung | Prostate | Other | |
---|---|---|---|---|---|---|---|---|---|
Distance Functional measure form | |||||||||
0.710 | 0.269 | 0.438 | 0.681 | 0.618 | 0.466 | 0.620 | 0.258 | ||
y1 | -0.073 | -0.0008 | -0.005 | -0.008 | -0.0011 | -0.0011 | -0.020 | -0.004 | |
-0.037 | 0.056 | ||||||||
A | -0.132 | 0.356 | 0.321 | 0.270 | 0.373 | 0.560 | 0.486 | 0.682 | |
AIC | -186.87 | -822.05 | -536.84 | -297.09 | -487.41 | -670.97 | -193.55 | -980.25 | |
AlC(linear) | -186.26 | -796.21 | -517.20 | -248.70 | -456.69 | -579.02 | -141.71 | -822.23 | |
SRMSE | 0.474 | 0.347 | 0.315 | 0.281 | 0.218 | 0.238 | 0.327 | 0.281 |
Model | Base-case utilisation | Prognosis utilisation | Utilisation change (%) |
---|---|---|---|
Overall | 0.453 | 0.466 | +3.05 |
Cancer-specific | 0.464 | 0.479 | +3.15 |
Cancer group | ICD-10* | Utilisation rate in 2012 | Counties with 0 courses in 2012 | |
---|---|---|---|---|
1. | Central nervous system | C70-C72 | 0.493 | 18 |
2. | Melanoma of skin | C43 | 0.260 | 108 |
3. | Head and neck | C00-C14, C30-C32 | 0.799 | 2 |
4. | Trachea, bronchus and lung | C33, C34 | 0.520 | 0 |
5. | Breast | C50, D05 | 0.787 | 0 |
6. | Lower gastrointestinal tract | C18-C21 | 0.264 | 2 |
7. | Upper gastrointestinal tract | C15, C16, C22-26 | 0.138 | 41 |
8. | Prostate | C61 | 0.717 | 3 |
9. | Female genital organs | C53, C54, C56, C57 | 0.458 | 3 |
10. | Kidney | C64-C66 | 0.159 | 83 |
11. | Bladder | C67 | 0.157 | 78 |
12. | Thyroid | C73 | 0.870 | 210 |
13. | Testicle | C62 | 0.136 | 211 |
14. | Other | C17, C37-C41, C45-C49, C51, C52, C55, C58, C60, C63, C68, C69, C74-C80, C97 | 0.547 | 1 |
Distance measure Functional form Model version | |||
---|---|---|---|
SEM | OLS | ||
0.452 | 0.501 | ||
-0.024 | -0.038 | ||
-0.046 | -0.086 | ||
0.710 | - | ||
−1,247.33 | −1,062.53 | ||
0.120 | 0.163 | ||
0.466 | 0.473 |